Single administration of novel antibody cocktail controlled patients' allergic response to cat allergen, preventing early asthma reactions for the duration of the 3-month trial Patients experienced ...
Regeneron Pharmaceuticals released positive Phase 2 trial results, which showed that a single dose of of its investigational antibody cocktail therapy prevented early asthma reactions in cat-allergic ...
Please provide your email address to receive an email when new articles are posted on . A single dose of Regeneron’s REGN1908/1909 significantly prevented reductions in FEV1 compared with placebo.
DALLAS -- As-needed treatment with a combination of the inhaled corticosteroid budesonide and the long-acting bronchodilator formoterol (Symbicort) outperformed as-needed albuterol and was on par with ...
Mild asthma could be better treated with the recent approval of the combination of albuterol/budesonide. The recent approval of albuterol/budesonide could change the way that mild asthma is treated in ...
According to a recent study presented at the American Thoracic Society International Conference in Dallas, Texas, and simultaneously published in the New England Journal of Medicine, nearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results